生分解性・再利用可能な圧電エラストマー/ポリ(l-乳酸)複合ナノファイバー膜を用いた慢性閉塞性肺疾患の人工知能支援による同定と予防
Xuan Ling1,2, Ting Han1, Pengfei Yang1
1School of Materials and Energy, University of Electronic Science and Technology of China, 611731 Chengdu, China.
Abstract:
Chronic obstructive pulmonary disease (COPD) is a respiratory disease imposing significant economic and health burdens to patients. The long latent period of COPD due to inhalation of PM 0.3 makes it difficult to prevent and identify the disease at an early stage. Herein, an environmentally friendly and long-term reliable nanofiber membrane with detection of COPD and filtration of PM 0.3 function is developed based on piezoelectric poly(l-lactic acid) (PLLA)/lactic acid-based copolyester piezoelectric elastomer (LCPE) composites. The LCPE is synthesized with low elastic modulus and high piezoelectricity, which firmly bonds with PLLA and acts as a stress concentration point in the fiber framework, converting local fiber vibrations into global film vibrations and helping to improve the acoustic-electric conversion of PLLA/LCPE nanofiber filtration membranes (PLNFM), which is 24 times that of neat PLLA under the same airflow. The PLNFM enables COPD identification by acoustic spectrum recognition through artificial intelligence (AI)-assisted algorithms, presenting a high recognition rate of over 92.3%. Meanwhile, the interwoven structure of PLNFM and the induced piezoelectric charge achieve PM 0.3 filtration efficiency as high as 99.975%. The respiratory disease identification function, high PM 0.3 filtration efficiency, and reusable performance of PLNFM provide great potential in intelligent wearable device fields.
さらに関連する動画
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
関連する概念動画
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
